Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness Study of the BioVac Direct Suction Device in Upper Gastrointestinal Bleeding

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~1. Patients presenting with fresh blood hematemesis, coffee ground emesis, or melena~2. Patients with hematochezia and hypotension (systolic blood pressure \< 90 mm Hg) or tachycardia (heart rate \> 110 beats per minute)~Exclusion Criteria~1. Identification of a bleeding source within the first 5 minutes of the upper endoscopy or no blood seen in the upper GI tract as these patients do not require additional suctioning.~2. Age \< 18.~3. No endoscopy was performed.~4. Endoscopy previously performed for current episode of UGIB.~5. Patients unable to consent and who do not have a substitute decision maker.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BioVac Direct Suction Device (Type: EXPERIMENTAL): Experimental arm
- Standard Endoscopy Suction (Type: ACTIVE_COMPARATOR): Control arm

Based on this trial design, predict the completion outcome and termination type (if applicable).